SCHEMBL2445773

SCHEMBL2445773

O=C(O)CC1CCN(Cc2c(Cl)cccc2Cl)CC1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 4/20 0.54
SIGMAR1 Q99720 1/20 0.52
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 3/20 0.50
CYP2A13 Q16696 1/20 0.50
POLB P06746 1/20 0.49
TSHR P16473 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
TDP1 Q9NUW8 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
OPRM1 P35372 1/20 0.46
OPRD1 P41143 1/20 0.46
OPRK1 P41145 1/20 0.46
OPRL1 P41146 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8237166 0.87 CXCR4 (0.56) CXCR4SIGMAR1KDM4EALDH1A1CYP2A13
SCHEMBL15338728 0.87 CXCR4 (0.53) CXCR4SIGMAR1KDM4EALDH1A1CYP2A13
SCHEMBL12401142 0.83 CXCR4 (0.53) CXCR4SIGMAR1KDM4EALDH1A1CYP2A13
SCHEMBL6747206 0.81 CXCR4 (0.65) CXCR4
Hydrochloric Acid SCHEMBL9537230 0.80 BCHE (0.63) CXCR4
SCHEMBL7659440 0.79 ALDH1A1 (0.61) SIGMAR1ALDH1A1MEN1KMT2A
SCHEMBL19084133 0.78 CYP2A13 (0.56) CXCR4SIGMAR1KDM4EALDH1A1CYP2A13
SCHEMBL5743274 0.77 SIGMAR1 (0.59) SIGMAR1KDM4EALDH1A1POLBSMN1; SMN2
SCHEMBL28551278 0.77 CYP2A13 (0.54) CXCR4SIGMAR1KDM4EALDH1A1CYP2A13
SCHEMBL10989980 0.75 KMT2A (0.62) SIGMAR1KDM4EALDH1A1CYP2A13TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed